Canntab Therapeutics Ltd
Change company Symbol lookup
Select an option...
CTABF Canntab Therapeutics Ltd
GTBP GT Biopharma Inc
UNH UnitedHealth Group Inc
BAC Bank of America Corp
WSO Watsco Inc
LITB LightInTheBox Holding Co Ltd
CVCY Central Valley Community Bancorp
AFAQU AF Acquisition Corp
HCIIW Hudson Executive Investment Equity II Warrant Exp 31 Jan 2027 *W EXP 01/31/2027
MEDS TRxADE Health Inc
Go


Based in Canada
Company profile

Canntab Therapeutics Limited is Canada-based biopharmaceutical company. The Company is focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company operates in one reportable operating, being engaged in the medical marijuana business. All property and equipment, right-of-use assets and intangible assets are located in Canada. Its hard pill cannabinoid formulations provide doctors, patients and consumers with medical grade solutions. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet. It holds cannabis standard processing and sales for medical purposes license, a cannabis research license, and an industrial hemp license from health Canada.

Closing Price
$0.22
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.22
Day's Low
0.22
Volume
(Heavy Day)
Volume:
2,000

10-day average volume:
1,638
2,000
  • Prev Close
    0.22
  • Today's Open
    0.22
  • Day's Range
    0.22-0.22
  • Avg Vol (10-day)
    1.6K
  • Last (time)
    2:20p ET 05/17/22
  • Last (size)
    500
  • 52-Wk Range
    0.22 - 0.8544
    LowHigh
  • (05/17/21 - 05/17/22)
    0.00%
  • 85.5%
  • Market Cap
    8.6M
  • Shares Outstanding
    38.9M
  • -0.13
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.3
  • 0.00
  • --

Events

There are no calendar events for CTABF.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.